S. E. Salmon

5.3k total citations · 1 hit paper
78 papers, 3.9k citations indexed

About

S. E. Salmon is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, S. E. Salmon has authored 78 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 31 papers in Oncology and 20 papers in Hematology. Recurrent topics in S. E. Salmon's work include Multiple Myeloma Research and Treatments (19 papers), Cancer Treatment and Pharmacology (19 papers) and Cancer therapeutics and mechanisms (11 papers). S. E. Salmon is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Cancer Treatment and Pharmacology (19 papers) and Cancer therapeutics and mechanisms (11 papers). S. E. Salmon collaborates with scholars based in United States, France and Switzerland. S. E. Salmon's co-authors include William S. Dalton, Thomas M. Grogan, Charles W. Taylor, DavidS. Alberts, TP Miller, Rik J. Scheper, Paul S. Meltzer, B G M Durie, Thomas E. Moon and H. Benfer Kaltreider and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

S. E. Salmon

76 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

1989 478 citations William S. Dalton, Thomas M. Grogan et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by S. E. Salmon

Since Specialization

Citations

This map shows the geographic impact of S. E. Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Salmon more than expected).

Fields of papers citing papers by S. E. Salmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. E. Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Salmon. The network helps show where S. E. Salmon may publish in the future.

Co-authorship network of co-authors of S. E. Salmon

This figure shows the co-authorship network connecting the top 25 collaborators of S. E. Salmon. A scholar is included among the top collaborators of S. E. Salmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. E. Salmon. S. E. Salmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Major Vault Protein (MVP), a New Multidrug Resistance Associated Protein, is Frequently Expressed in Multiple Myeloma 1999 ·Leukemia & lymphoma ·(unknown), (unknown), (unknown), S. E. Salmon, (unknown), (unknown)	18
2	Clinical feasibility of 0.018-inch intravascular ultrasound imaging device 1998 ·American Heart Journal ·Takafumi Hiro, (unknown), Luigi Maiello, Akira Itoh, Antonio Colombo, (unknown), S. E. Salmon, Jonathan M. Tobis	1
3	Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study. 1998 ·Journal of Clinical Oncology ·Eric H. Kraut, John J. Crowley, James L. Wade, Leslie R. Laufman, M. Alsina, Sarah A. Taylor, S. E. Salmon	37
4	Serum can inhibit reversal of multidrug resistance by chemosensitisers 1996 ·European Journal of Cancer ·M. Lehnert, Rita de Giuli, Kathleen Kunke, Scott S. Emerson, William S. Dalton, S. E. Salmon	23
5	Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. 1996 ·Journal of Clinical Oncology ·Manuel Modiano, (unknown), John Crowley, S. E. Salmon	29
6	CLINICAL FEASIBILITY OF AN 0.018-INCH INTRAVASCULAR ULTRASOUND IMAGING DEVICE 1995 ·Circulation ·Jonathan M. Tobis, Patrick Hall, Luigi Maiello, Akihiro Ito, (unknown), S. E. Salmon, Antonio Colombo	1
7	In Vitro Drug Testing of Ovarian Cancer Using the Human Tumor Colony-Forming Assay: Comparison of in Vitro Response and Clinical Outcome 1994 ·Gynecologic Oncology ·Massimo Federico, David S. Alberts, (unknown), Julia Emerson, Paul T. Fanta, Ruixia Liu, S. E. Salmon	11
8	Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study. 1994 ·Journal of Clinical Oncology ·S. E. Salmon, John J. Crowley, Thomas M. Grogan, Patrick R. Finley, Reginald P. Pugh, Bart Barlogie	102
9	Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin cholesterol acyltransferase activation 1993 ·Atherosclerosis ·Jean‐Claude Mazière, I. Myara, S. E. Salmon, Martine Auclair, Josiane Haigle, R. Santus, (unknown)	40
10	Effects of Suramin on In Vitro Growth of Fresh Human Tumors 1992 ·JNCI Journal of the National Cancer Institute ·Charles W. Taylor, Rashid N. Lui, Paul T. Fanta, S. E. Salmon	39
11	Antiproliferative and Antitumor Activity of the 2-Cyanoaziridine Compound Imexon on Tumor Cell Lines and Fresh Tumor Cells In Vitro 1992 ·JNCI Journal of the National Cancer Institute ·E. M. Hersh, (unknown), Charles W. Taylor, R T Dorr, Raymond Taetle, S. E. Salmon	30
12	Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study. 1990 ·Journal of Clinical Oncology ·S. E. Salmon, (unknown), John Crowley, Sheikh M. Saeed, Patrick R. Finley, M. Milder, Laura F. Hutchins, Charles A. Coltman, John D. Bonnet, Bruce D. Cheson	40
13	Antineoplastic effects of tumor necrosis factor alone and in combination with gamma-interferon on tumor biopsies in clonogenic assay. 1987 ·Journal of Clinical Oncology ·S. E. Salmon, Lai-Sang Young, Philip Scuderi, Brendan Clark	29
14	Application of a human tumor colony-forming assay to new drug screening. 1985 ·PubMed ·Robert H. Shoemaker, Mary K. Wolpert-DeFilippes, David H. Kern, Michael M. Lieber, Robert Makuch, (unknown), Wallace T. Miller, S. E. Salmon, Richard Simon, John M. Venditti	179
15	Combination chemotherapy (CRx) in vitro with the human tumor stem cell assay (HTSCA) 1981 ·Proceedings of the American Association for Cancer Research ·David S. Alberts, S. E. Salmon, Earl A. Surwit	3
16	Quantitation of drug sensitivity by human metastatic melanoma colony-forming units 1981 ·British Journal of Cancer ·Frank L. Meyskens, Thomas E. Moon, Bruce W. Dana, Emilio Gil‐Martín, (unknown), (unknown), D. Franks, Lai-Sang Young, S. E. Salmon	40
17	Cloning of human tumor stem cells 1980 ·S. E. Salmon	78
18	Clinical Correlations of Drug Sensitivity in the Human Tumor Stem Cell Assay 1980 ·Recent results in cancer research ·S. E. Salmon, David S. Alberts, Brian G.M. Durie, Frank L. Meyskens, Stephen E. Jones, B Soehnlen, (unknown), Thomas E. Moon	49
19	Treatment of Early Breast Cancer With Adriamycin-Cyclophosphamide With or Without Radiation Therapy: Initial Results of a Brief and Effective Adjuvant Program 1979 ·Recent results in cancer research ·S. E. Salmon, (unknown), Stephen E. Jones, Rebecca L. Jackson, Giovanna Giordano, Robert C. Miller, Robert S. Heusinkveld, Thomas E. Moon	7
20	Biologic Activities of Aggregated γ-Globulin 1967 ·The Journal of Immunology ·(unknown), (unknown), S. E. Salmon, (unknown)	125

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact